Background illustration for clinical trials search

Sarcoma Clinical Trials

Browse 918 sarcoma clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

CD4CAR for CD4+ Leukemia and Lymphoma

for
T-cell Lymphoma, T-cell Leukemia
Location: New York NY, Miami FL, Indianapolis IN, Houston TX
Sponsor: Huda Salman

Sex: All

Age: 12+

Code: NCT03829540

Phase1, Recruiting

Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies

for
B-Cell Non-Hodgkin Lymphoma,
Location: Westwood KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18+

Code: NCT06879340

Phase1, Recruiting

Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma

for
Recurrent Grade 1 Follicular Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06453044

Phase2, Recruiting

BHB & CAR-T for Lymphomas

for
Large B-cell Lymphoma
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT06610344

Recruiting

A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas

for
Lymphomas, B-cell Lymphomas
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05773040

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

for
Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma,
Location: Boston MA, New York NY, Philadelphia PA, Miami FL,
Sponsor: AstraZeneca

Sex: All

Age: 12+

Code: NCT06137144

Phase1, Phase2, Recruiting

MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma

for
Autologous Stem Cell Transplant, Classic Hodgkin Lymphoma
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 18+

Code: NCT06377540

Phase2, Recruiting

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

for
Solid Tumor, Adult, Triple Negative Breast Cancer,
Location: Scottsdale AZ, La Jolla CA, Stanford CA
Sponsor: BioEclipse Therapeutics

Sex: All

Age: 18+

Code: NCT04282044

Phase1, Recruiting

A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides

for
Cutaneous T-cell Lymphoma
Location: Commack NY, Rockville Centre NY, New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05296304

Phase1, Recruiting

Upfront Surgical Resection for Osteosarcoma

for
Osteosarcoma
Location: The Bronx NY
Sponsor: Montefiore Medical Center

Sex: All

Age: 5 - 40

Code: NCT06384404

Recruiting

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

for
Hematologic Malignancy, Large B-cell Lymphoma,
Location: Los Angeles CA
Sponsor: Joshua Sasine, MD, PhD

Sex: All

Age: 18 - 70+

Code: NCT05887167

Phase1, Recruiting

Pembro Plus CAR T-cell Therapy in R/R in PMBCL

for
Primary Mediastinal Large B-cell Lymphoma (PMBCL),
Location: Boston MA, New York NY
Sponsor: Jennifer Crombie, MD

Sex: All

Age: 18+

Code: NCT05934448

Phase2, Recruiting

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

for
Peripheral T-Cell Lymphoma, Not Otherwise Specified,
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Corvus Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06561048

Phase3, Recruiting

CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL).

for
Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma,
Location: Miami FL
Sponsor: Lazaros Lekakis

Sex: All

Age: 18 - 70+

Code: NCT05260957

Phase2, Recruiting

Study for Subjects With Relapsed/Refractory Non- Hodgkin Lymphoma

for
Non Hodgkin's Lymphoma Refractory/Relapsed
Location: Tyler TX, Newport Beach CA
Sponsor: ImmunityBio, Inc.

Sex: All

Age: 18+

Code: NCT05618925

Phase1, Recruiting

Registry of Older Patients With Cancer

for
Chronic Myeloproliferative Disorders,
Location: Morehead City NC, New Bern NC, Greenville NC,
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 65+

Code: NCT01137825

Recruiting

Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

for
Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Location: Boston MA, New York NY, Hackensack NJ, Rochester NY,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 8+

Code: NCT06098430

Recruiting

ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

for
Lymphoma, Lymphoma, B-Cell, Diffuse Large B Cell Lymphoma,
Location: New York NY
Sponsor: Hua-Jay J Cherng, MD

Sex: All

Age: 18+

Code: NCT06693830

Recruiting

Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT04560322

Phase2, Recruiting

Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications

for
Lymphoma, Chemotherapeutic Toxicity
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: All

Age: 60+

Code: NCT04053439

Recruiting